Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas

Histopathology

Volumn 39, Issue 4, 2001, Pages 409-415

  Chaudhry, I H ^a   O'Donovan, D G ^a   Brenchley, P E C ^b   Reid, H ^a   Roberts, I S D ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Astrocytoma; Oligodendroglioma; Vascular endothelial growth factor

Indexed keywords

EPITOPE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; CANCER GRADING; CONTROLLED STUDY; CYTOSOL; ENDOTHELIUM CELL; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RECEPTOR BINDING; TUMOR CELL; TUMOR VASCULARIZATION; VASCULARIZATION;

ASTROCYTOMA; ENDOTHELIAL GROWTH FACTORS; GLIOBLASTOMA; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; OLIGODENDROGLIOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034757675     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01230.x     Document Type: Article

References (52)

1. National survey of patterns of care for brain tumour patients
2. Tumour angiogenesis in advanced stage ovarian carcinoma
3. Overexpression of vascular endothelial growth factor is responsible for the hematogenous recurrence of early-stage gastric carcinoma
4. Angiogenesis: An indicator of metastasis in non-small cell lung cancer invading the thoracic inlet
5. Tumour angiogenesis and rectal carcinoma
6. Tumour angiogenesis and metastasis - Correlation in invasive breast carcinoma
7. Co-expression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance
8. The potential role of basic fibroblast growth factor in the transformation of cultured primary human fetal astrocytes and the proliferation of human glioma (U-87) cells
9. Epidermal growth factor stimulate vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology
10. Growth factors and proliferation potential
11. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms
12. Expression of vascular endothelial growth factor and its possible relation with neovascularisation in human brain tumours
13. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumours and other disorders
14. Biology and treatment of malignant glioma
15. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
16. Identification of the KDR tyrosine kinase, as a receptor for vascular endothelial growth factor
17. Abnormal vessel development and lethality in embryos lacking a single VEGF allele
18. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
19. Angiogenesis in embryos and ischemic diseases
20. Molecular mechanisms of development of tumour angiogenesis
21. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
22. Expression and distribution of vascular endothelial growth factor protein in human brain tumours
23. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low grade astrocytoma
24. Are keratin proteins a better tumour marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies
25. Methods for the quantitative morphological analysis of tissues
26. Tumour angiogenesis: Therapeutic implications
27. Vascular endothelial growth factor (VEGF) and its receptors
28. New model of tumour angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
29. Quantitative analysis of vascular endothelial growth factor in primary breast cancer
30. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
31. Different angiogenic pathways characterise superficial and invasive bladder cancer
32. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
33. Angiogenesis in cancer and other diseases
34. Implication of vascular endothelial growth factor in the development and metastasis of human cancers
35. Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localisation of VEGF in tissue sections: Expression of VEGF in the human endometrium
36. Vascular endothelial growth factor
37. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
38. Vascular endothelial growth factor (VEGF) isoforms - Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF
39. Angiogenesis in malignant gliomas
40. Vascular morphology and angiogenesis in glial tumors
41. Immunolocalization of granulocyte-colony-stimulating factor in human glial and primitive neuroectodermal tumours
42. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis
43. Expression of hypoxia inducible factor alpha in brain tumours: Association with angiogenesis, invasion, and progression
44. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
45. Vascular endothelial growth factor and glioma angiogenesis: Co-ordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
46. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
47. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression
48. Antagonising the expression of VEGF in pathological angiogenesis
49. Antiangiogenic therapy in brain tumour models
50. Tumour angiogenesis: Past, present and the near future
51. Current status of antiangiogenic factors